Skip to content

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

Where next for the Alibaba share price?

Last week’s surge in Chinese technology stocks in the wake of its government announcing a stimulus package, kicked off a swift bullish reversal which is expected to continue for shares like Alibaba.

Source: Bloomberg

Shares in the Chinese ecommerce group, Alibaba surged by over 11% as the company upsized its share buyback programme from $8 billion to $25 billion on Tuesday, the largest ever repurchase plan by the company.

The upsurge came on the back of a more than 40% rally in the Alibaba share price from last week’s $72.24 low after Chinese Vice Premier, Liu He, said that Beijing will rout out more measures to boost the economy and hinted at an end to the Chinese government’s restrictive regulatory environment.

Last week Alibaba stock quoted in China had its biggest one-day gain since 2014, rising by around 37%, with it soaring by more than 20% in US trading.

Source: ProRealTime

Chinese regulatory risks, US disclosure requirements and Beijing's alliance with Russia, all posed a threat to the delisting of Chinese companies and have contributed to investors selling stocks such as Alibaba which declined by around 75% from its $319.27 October 2020 high.

Can Alibaba’s eye-watering bullish reversal continue?

The sharp rally in Alibaba's share price on the New York Stock Exchance (NYSE) has taken it from last week’s $72.24 low through the December-to-January lows and resistance area at $108.76 to $110.41 with the $120 region about to be hit, a rise of some 60%.

Given the strength of last week’s bullish reversal and this week’s follow through to the upside, the current rally in the Alibaba share price is expected to continue, especially since it has broken through its six-month downtrend line and risen above the 55-day simple moving average (SMA) at $115.29.

A potential upside target is the $129.39 February high. 

Source: ProRealTime

Further potential targets are seen between the 2020-to-2022 downtrend line and the January high at $132.80 to $138.60.

The bulls are to remain in charge while the Alibaba share price stays above the 24 February low at $99.67 on a daily chart closing basis.  One should see the current strong rally in the Alibaba share price within the context of its approximately 75% decline from its $319.27 October 2020 high to last week’s $72.24 low, though.

This large decline was caused by the Chinese government’s crackdown on its technology companies, such as Alibaba, which haven’t as yet been lifted, despite its recent hints.

Act on share opportunities today

Go long or short on thousands of international stocks with spread bets and CFDs.

  • Get full exposure for a comparatively small deposit
  • Trade on spreads from just 0.1%
  • Get greater order book visibility with direct market access
Learn more

See opportunity on a stock?

Try a risk-free trade in your demo account, and see whether you’re on to something.

  • Log in to your demo
  • Take your position
  • See whether your hunch pays off
Log in now

See opportunity on a stock?

Don’t miss your chance – upgrade to a live account to take advantage.

  • Trade a huge range of popular stocks
  • Analyse and deal seamlessly on fast, intuitive charts
  • See and react to breaking news in-platform
Log in now

See opportunity on a stock?

Don’t miss your chance. Log in to take advantage while conditions prevail.

Take advantage

Related articles

Live prices on most popular markets

  • Equities
  • Indices
  • Forex
  • Commodities


Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Monday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.


You might be interested in…

<h3>How much does trading cost?</h3>
<h3>Find out about IG</h3>
<h3>Plan your trading</h3>

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.


This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.